The role of WNT in rheumatoid arthritis and its therapeutic implication

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 3, 2009, Pages 318-323

  Imai, Kazushi ^a   Chiba, Tadashige ^a   Maeda, Genta ^a   Morikawa, Masako ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

FRP; Matrix metalloproteinase; Rheumatoid arthritis; Synovium; WNT; catenin

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ABATACEPT; ACETYLSALICYLIC ACID; ADALIMUMAB; ANTIINFLAMMATORY AGENT; CPG 049090; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ESTROGEN; ETANERCEPT; FH 535; FJ 9; GROWTH FACTOR; ICG 001; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; PKF 115 584; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 INDUCIBLE SIGNALING PATHWAY PROTEIN;

DISEASE COURSE; DRUG TARGETING; FIBROBLAST; GENE DELETION; GENE MUTATION; GENE TARGETING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BONE; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE AND BONES; ESTROGENS; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; WNT PROTEINS;

EID: 65349134126     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557510909030318     Document Type: Review

References (53)

1. Cutolo, M.; Seriolo, B.; Villaggio, B.; Pizzorni, C.; Craviotto, C.; Sulli, A. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann. N. Y. Acad. Sci., 2002, 966, 131-42.
2. Tengstrand, B.; Carlstrom, K.; Fellander-Tsai, L.; Hafstrom, I. Abnormal levels of serum dehydroepiandrosterone, estrogen, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J. Rheumatol., 2003, 30, 2338-43.
3. Castagnetta, L.A.; Carruba, G.; Granata, O.M.; Stefano, R.; Miele, M.; Schmidt, M.; Cutolo, M.; Straub, R.H. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J. Rheumatol., 2003, 30, 2597-605.
4. Itoh, Y.; Hayashi, H.; Miyazawa, K.; Kojima, S.; Akahoshi, T.; Onozaki, K. 17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalpha. J. Immunol., 2007, 178, 3059-66.
5. Tanaka, I.; Morikawa, M.; Okuse, T.; Shirakawa, M.; Imai, K. Expression and regulation of WISP2 in rheumatoid arthritic synovium. Biochem. Biophys. Res. Commun., 2005, 334, 973-8.
6. Carruba, G.; D'Agostino, P.; Miele, M.; Barbera, C.; Bella, G.D.; Milano, S.; Feriazzo, V.; Caruso, R.; Rosa, M.L.; Cocciadiferro, L.; Campisi, I.; Castagnetta, L.; Cillari, E. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J. Cell Biochem., 2003, 90, 187-96.
7. Firestein, G.S. Evolving concepts of rheumatoid arthritis. Nature, 2003, 423, 356-61.
8. Firestein, G.S.; Alvaro-Gracia, J.M.; Maki, R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol., 1990, 144, 3347-53.
9. Imai, K.; Dalal, S.S.; Hambor, J.; Mitchell, P.; Okada, Y.; Horton, W.C.; D'Armiento, J. Bone growth retardation in mouse embryos expressing human collagenase 1. Am. J. Physiol. Cell Physiol., 2007, 293, C1209-15.
10. Imai, K.; Okada, Y. Purification of matrix metalloproteinases by column chromatography. Nat. Prot., 2008, 3, 1111-24.
11. Yamanishi, Y.; Boyle, D.L.; Clark, M.; Maki, R.A.; Tortorella, M.D.; Arner, E.C.; Firestein, G.S. Expression and regulation of aggrecanase in arthritis: the role of TGF-β. J. Immunol., 2002, 168, 1405-12.
12. Abeles, A.M.; Pillinger, M.H. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull. NYU Hosp. Jt. Dis., 2006, 64, 20-4.
13. Pap, T.; Muller-Ladner, U.; Gay, R.E.; Gay, S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res., 2000, 2, 361-7.
14. Lee, D.M.; Weinblatt, M.E. Rheumatoid arthritis. Lancet, 2001, 358, 903-11.
15. Seidensticker, M.J.; Behrens, J. Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta, 2000, 1495, 168-82.
16. Peifer, M.; Polakis, P. Wnt signaling in oncogenesis and embryo-genesis - a look outside the nucleus. Science, 2000, 287, 1606-9.
17. Uraguchi, M.; Morikawa, M.; Shirakawa, M.; Sanada, K.; Imai, K. Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity. J. Dent. Res., 2004, 83, 327-32.
18. Huang, H.C.; Klein, P.S. The Frizzled family: receptors for multiple signal transduction pathways. Genome Biol., 2004, 5, 234.
19. Qu, Z.; Garcia, C.H.; O'Rourke, L.M.; Planck, S.R.; Kohli, M.; Rosenbaum, J.T. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum., 1994, 37, 212-20.
20. Kobayashi, A.; Naito, S.; Enomoto, H., Shiomi, T.; Kimura, T.; Obata, K.; Inoue, K.; Okada, Y. Serum levels of matrix metallo-proteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis. Arch. Pathol. Lab. Med., 2007, 131, 563-70.
21. Busso, N.; Péclat, V.; van Ness, K.; Kolodziesczyk, E.; Degen, J.; Bugge, T.; So, A. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J. Clin. Invest., 1998, 102, 41-50
22. Fujii, K.; Fujii, Y.; Hubscher, S.; Tanaka, Y. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J. Immunol., 2001, 167, 1198-203.
23. Mould, A.W.; Tonks, I.D.; Cahill, M.M.; Pettit, A.R.; Thomas, R.; Hayward, N.K.; Kay, G.F. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum., 2003, 48, 2660-9.
24. Sen, M.; Reifert, J.; Lauterbach, K.; Wolf, V.; Rubin, J.S.; Corr, M.; Carson, D.A. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum., 2002, 46, 2867-77.
25. Sen, M.; Lauterbach, K.; El-Gabalawy, H.; Firestein, G.S.; Corr, M.; Carson, D.A. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 2000, 97, 2791-6.
26. Nakamura, Y.; Nawata, M.; Wakitani, S. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am. J. Pathol., 2005, 167, 97-105.
27. Imai, K.; Morikawa, M.; D'Armiento, J.; Matsumoto, H.; Komiya, K.; Okada, Y. Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis. Biochem. Biophys. Res. Commun., 2006, 345, 1615-20.
28. Diarra, D.; Stolina, M.; Polzer, K.; Zwerina, J.; Ominsky, M.S.; Dwyer, D.; Korb, A.; Smolen, J.; Hoffmann, M.; Scheinecker, C.; van der Heide, D.; Landewe, R.; Lacey, D.; Richards, W.G.; Schett, G. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med., 2007, 13, 156-63.
29. Rodda, S.J.; McMahon, A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development, 2006, 133, 3231-44.
30. Holmen, S.L.; Zylstra, C.R.; Mukherjee A.; Sigler, R.E.; Faugere, M.C.; Bouxsein, M.L.; Deng, L.; Clemens, T.L.; Eilliams, B.O. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem., 2005, 280, 21162-8.
31. Li, X.; Liu, P.; Liu, W.; Maye, P.; Zhang, J.; Zhang, Y.; Hurley, M.; Guo, C.; Boskey, A.; Sun, L.; Harris, S.E.; Rowe, D.W.; Ke, H.Z.; Wu, D. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat. Genet., 2005, 37, 945-52.
32. Morvan, F.; Boulukos, K.; Clément-Lacroix, P.; Roman Roman, S.; Suc-Royer, I.; Vayssiére, B.; Ammann, P.; Martin, P.; Pinho, S., Pognonec, P.; Mollat, P.; Niehrs, C.; Baron, R.; Rawadi, G. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res., 2006, 21, 934-45.
33. Bodine, P.V.; Zhao, W.; Kharode, Y.P.; Bex, F.J.; Lambert, A.J.; Goad, M.B.; Gaur, T.; Stein, G.S.; Lian, J.B.; Komm, B.S. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol., 2004, 18, 1222-37.
34. Zhu, M.; Tang, D.; Wu, Q.; Hao, S.; Chen, M.; Xie, C.; Rosier, R.; O'Keefe, R.; Zuscik, M.; Chen, D. Activation of beta-Catenin Signaling in Articular Chondrocytes Leads to Osteoarthritis-Like Phenotype in Adult beta-Catenin Conditional Activation Mice. J. Bone Miner. Res., 2008, early publication online.
35. Zhu, M.; Chen, M.; Zuscik, M.; Wu, Q.; Wang, Y.J.; Rosier, R.N.; O'Keefe, R.J.; Chen, D. Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum., 2008, 58, 2053-64.
36. Perbal, B. CCN proteins: multifunctional signalling regulators. Lancet, 2004, 363, 62-4.
37. El-Tanani, M.; Fernig, D.G.; Barraclough, R.; Green, C.; Rudland, P. Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. J. Biol. Chem., 2001, 276, 41675-82.
38. Kouzmenko, A.P.; Takeyama, K.; Ito, S.; Furutani, T.; Sawatsubashi, S.; Maki, A.; Suzuki, E.; Kawasaki, Y.; Akiyama, T.; Tabata, T.; Kato, S. Wnt/b-catenin and estrogen signaling converge in vivo. J. Biol. Chem., 2004, 279, 40255-8.
39. Hurvitz, J.R.; Suwairi, W.M.; van Hul, W.; El Shanti, H.; Superti-Furga, A.; Roudier, J.; Holderbaum, D.; Pauli, R.M.; Herd, J.K.; van Hul, E.V.; Rezai-Delui, H., Legius, E.; Le Merrer, M., Al-Alami, J.; Bahabri, S.A.; Warman, M.L. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet., 1999, 23, 94-7.
40. Lamb, R.; Thomson, W.; Ogilvie, E.; the British Society of Paediatric and Adolescent Rheumatolgy; Donn, R. Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum., 2005, 52, 3548-53.
41. Feldmann, M.; Maini, R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol., 2001, 19, 163-96.
42. Lipsky, P.E.; van der Heijde, D.M.; St. Clair, E.W.; Furst, D.E.; Breedveld, F.C.; Kalden, J.R.; Smolen, J.S.; Weisman, M.; Emery, P.; Feldmann, M.; Harriman, G.R.; Maini, R.N. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N. Engl. J. Med., 2000, 343, 1594-602.
43. Jochems, C.; Islander, U.; Kallkopf, A.; Lagerquist, M.; Ohlsson, C.; Carlsten, H. Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. Arthritis Rheum., 2007, 56, 3261-70.
44. Smolen, J.S.; Aletaha, D.; Keystone, E. Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction? Arthritis Rheum., 2005, 52, 2975-83.
45. Handeli, S.; Simon, J.A. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities. Mol. Cancer Ther., 2008, 7, 521-9.
46. McMillan, M.; Kahn, M. Investigating Wnt signaling: a chemogenomic safari. Drug Discov. Today, 2005, 10, 1467-74.
47. Lepourcelet, M.; Chen, Y.N.P.; France, D.S.; Wang, H.; Crews, P.; Petersen, F.; Bruseo, C.; Wood, A.W.; Shivdasani, R.A. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell, 2004, 5, 91-102.
48. Nath, N; Kashfi, K.; Chen, J.; Rigas, B. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. Proc. Natl. Acad. Sci. USA, 2003, 100, 12584-89.
49. Fujii, N.; You, L.; Xu, Z.; Uematsu, K.; Shan, J.; He, B.; Mikami, I.; Edmondson, L.R.; Neale, G.; Zheng, J.; Guy, R.K.; Jablons, D.M. An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res., 2007, 67, 573-9.
50. Barker, N.; Clevers, H. Mining the Wnt pathway for cancer therapeutics. Nat. Rev. Drug. Discov., 2006, 5, 997-1014.
51. Soden, M.; Rooney, M.; Cullen, A.; Whelan, A.; Feighery, C.; Bresnihan, B. Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. Br. J. Rheumatol., 1989, 28, 287-92.
52. Bukhari, M.; Thomson, W.; Naseem, H.; Bunn, D.; Silman, A.; Symmons, D.; Barton, A. The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum., 2007, 57, 2929-35.
53. van Oosterhout, M.; Bajema, I.; Levarht, E.W.; Toes, R.E.; Huizinga, T.W.; van Laar, J.M. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum., 2008, 58, 53-60.